Temat: "Anti-Anxiety Agents" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Nitric Oxide (NO) Synthase Inhibitors: Potential Candidates for the Treatment of Anxiety Disorders?
Autorzy:: Pitsikas N; Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Thessaly, Biopolis, Panepistimiou 3, 415-00 Larissa, Greece.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2024 Mar 21; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Nitric Oxide*
Anti-Anxiety Agents*/pharmacology
Anti-Anxiety Agents*/therapeutic use
Humans ; Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/therapeutic use ; Anxiety Disorders/drug therapy ; Anxiety/drug therapy ; Anxiety/etiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Impact of benzodiazepine use on the risk of occupational accidents.
Autorzy:: Baudot FO; ERUDITE, Université Paris-Est Créteil, Créteil, France.; Caisse Nationale de l'Assurance Maladie, Paris, France.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 16; Vol. 19 (4), pp. e0302205. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Accidents, Occupational*
Anti-Anxiety Agents*/adverse effects
Benzodiazepines*/adverse effects
Humans ; Anxiety Disorders/drug therapy ; European People

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
Autorzy:: Bhardwaj AK; Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia. .; Drug and Alcohol Services, South East Sydney Local Health District, Sydney, NSW, Australia. .
Mills L; Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia.; Drug and Alcohol Services, South East Sydney Local Health District, Sydney, NSW, Australia.
Doyle M; Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia.
Sahid A; Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia.; Drug and Alcohol Services, South East Sydney Local Health District, Sydney, NSW, Australia.
Montebello M; Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia.; Drug and Alcohol Services, North Sydney Local Health District, St Leonards, NSW, Australia.
Monds L; Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia.; Drug and Alcohol Services, North Sydney Local Health District, St Leonards, NSW, Australia.
Arunogiri S; Centre for Addiction and Mental Health, Turning Point, Victoria, Australia.
Haber P; Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia.; Drug Health Services, Sydney Local Health District, Sydney, Australia.
Lorenzetti V; Faculty of Health Science, Australian Catholic University, Victoria, Australia.
Lubman DI; Centre for Addiction and Mental Health, Turning Point, Victoria, Australia.
Malouf P; Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
Harrod ME; NSW Users and AIDS Association, Sydney, NSW, Australia.
Dunlop A; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia.
Freeman T; Addiction and Mental Health Group, University of Bath, Bath, UK.
Lintzeris N; Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia.; Drug and Alcohol Services, South East Sydney Local Health District, Sydney, NSW, Australia.; Pokaż więcej
Źródło:: BMC psychiatry [BMC Psychiatry] 2024 Mar 04; Vol. 24 (1), pp. 175. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Cannabidiol*/therapeutic use
Anti-Anxiety Agents*
Hallucinogens*
Substance-Related Disorders*
Cannabis*
Antipsychotic Agents*
Marijuana Abuse*
Adult ; Humans ; Quality of Life ; Australia ; Randomized Controlled Trials as Topic ; Clinical Trials, Phase III as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open-labeled randomized control trial.
Autorzy:: Chen H; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Lin Y; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.; Department of Neurology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, China.
Zhao Z; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Lin T; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Lin Q; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Chen X; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Wu W; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Zeng G; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Wu S; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Liu N; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Chen H; Gynecology Department, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Chen R; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Xiao Y; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.; Pokaż więcej
Źródło:: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14650.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Anti-Anxiety Agents*
Isoindoles*
Medically Unexplained Symptoms*
Piperazines*
Pyrimidines*
Vascular Depression*
Humans ; Citrates ; Depression/drug therapy ; Selective Serotonin Reuptake Inhibitors ; Serotonin ; Treatment Outcome ; Venlafaxine Hydrochloride/therapeutic use ; Drug Therapy, Combination/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: New users of anxiolytics and sedatives in Sweden-Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients.
Autorzy:: Dahlén E; The Swedish Medical Products Agency, Uppsala, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Bardage C; The Swedish Medical Products Agency, Uppsala, Sweden.
Tuvendal P; The Swedish Medical Products Agency, Uppsala, Sweden.
Ljung R; The Swedish Medical Products Agency, Uppsala, Sweden.; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Pokaż więcej
Źródło:: International journal of methods in psychiatric research [Int J Methods Psychiatr Res] 2024 Mar; Vol. 33 (1), pp. e1998.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Anxiety Agents*/therapeutic use
Male ; Adult ; Humans ; Female ; Hypnotics and Sedatives/therapeutic use ; Sweden/epidemiology ; Cohort Studies ; Benzodiazepines/therapeutic use ; Comorbidity ; Drug Prescriptions

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: The delta opioid receptor agonist KNT-127 relieves innate anxiety-like behavior in mice by suppressing transmission from the prelimbic cortex to basolateral amygdala.
Autorzy:: Kawaminami A; Laboratory of Pharmacology, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
Yamada D; Laboratory of Pharmacology, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
Yoshioka T; Laboratory of Pharmacology, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
Hatakeyama A; Laboratory of Pharmacology, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
Nishida M; Laboratory of Pharmacology, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
Kajino K; International Institute for Integrative Sleep Medicine (WPI-IIIS), Tsukuba, Japan.
Saitoh T; International Institute for Integrative Sleep Medicine (WPI-IIIS), Tsukuba, Japan.
Nagase H; University of Tsukuba, Tsukuba, Japan.
Saitoh A; Laboratory of Pharmacology, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.; Pokaż więcej
Źródło:: Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Mar; Vol. 44 (1), pp. 256-261. Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:: Journal Article
MeSH Terms:: Basolateral Nuclear Complex*/metabolism
Anti-Anxiety Agents*
Morphinans*
Mice ; Animals ; Male ; Receptors, Opioid, delta/agonists ; Receptors, Opioid, delta/metabolism ; Mice, Inbred C57BL ; Anxiety ; Analgesics, Opioid

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two-year period of pharmacotherapy.
Autorzy:: Mori K; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Kodaka F; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Yamamoto A; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Yamazaki R; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Ishii J; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Yamadera W; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.; Department of Psychiatry, Jikei University Katsushika Medical Center, Tokyo, Japan.
Miyata H; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Shigeta M; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.; Pokaż więcej
Źródło:: Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Mar; Vol. 44 (1), pp. 67-72. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:: Journal Article
MeSH Terms:: Selective Serotonin Reuptake Inhibitors*
Anti-Anxiety Agents*
Humans ; Female ; Anxiety Disorders ; Benzodiazepines ; Prescriptions

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Situational anxiety in head and neck cancer: Rates, patterns and clinical management interventions in a regional cancer setting.
Autorzy:: Forbes E; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Clover K; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; PsychoOncology Service, Department of Consultation Liaison Psychiatry, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Oultram S; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Radiation Oncology Department, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Wratten C; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Radiation Oncology Department, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Kumar M; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Radiation Oncology Department, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Tieu MT; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Radiation Oncology Department, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Carter G; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Department of Consultation Liaison Psychiatry, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
McCarter K; School of Psychological Sciences, College of Science, Engineering and Environment, University of Newcastle, Callaghan, New South Wales, Australia.
Britton B; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter New England Mental Health Services, Newcastle, New South Wales, Australia.
Baker AL; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Pokaż więcej
Źródło:: Journal of medical radiation sciences [J Med Radiat Sci] 2024 Mar; Vol. 71 (1), pp. 100-109. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Anxiety Agents*
Head and Neck Neoplasms*/radiotherapy
Humans ; Anxiety/epidemiology ; Anxiety/therapy ; Patients ; Australia

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Clove volatile oil-loaded nanoemulsion reduces the anxious-like behavior in adult zebrafish.
Autorzy:: da Silva Campelo M; Laboratório de Polímeros e Inovação de Materiais, Departamento de Química Orgânica e Inorgânica, Centro de Ciências, Universidade Federal do Ceará, Campus do Pici, CE, 60455-760, Fortaleza, Brasil.
Câmara Neto JF; Laboratório de Polímeros e Inovação de Materiais, Departamento de Química Orgânica e Inorgânica, Centro de Ciências, Universidade Federal do Ceará, Campus do Pici, CE, 60455-760, Fortaleza, Brasil.
de Souza ÁL; Laboratório de Polímeros e Inovação de Materiais, Departamento de Química Orgânica e Inorgânica, Centro de Ciências, Universidade Federal do Ceará, Campus do Pici, CE, 60455-760, Fortaleza, Brasil.
Ferreira MKA; Laboratório de Produtos Naturais, Centro de Ciência e Tecnologia, Universidade Estadual do Ceará, Campus Itaperi, 60714-903, Fortaleza, CE, Brasil.
Dos Santos HS; Laboratório de Produtos Naturais, Centro de Ciência e Tecnologia, Universidade Estadual do Ceará, Campus Itaperi, 60714-903, Fortaleza, CE, Brasil.; Centro de Ciência e Tecnologia - Curso de Química, Universidade Estadual Vale do Acaraú, 62010-295, Sobral, CE, Brasil.
Gramosa NV; Laboratório de Polímeros e Inovação de Materiais, Departamento de Química Orgânica e Inorgânica, Centro de Ciências, Universidade Federal do Ceará, Campus do Pici, CE, 60455-760, Fortaleza, Brasil.
de Aguiar Soares S; Laboratório de Polímeros e Inovação de Materiais, Departamento de Química Orgânica e Inorgânica, Centro de Ciências, Universidade Federal do Ceará, Campus do Pici, CE, 60455-760, Fortaleza, Brasil.
Ricardo NMPS; Laboratório de Polímeros e Inovação de Materiais, Departamento de Química Orgânica e Inorgânica, Centro de Ciências, Universidade Federal do Ceará, Campus do Pici, CE, 60455-760, Fortaleza, Brasil.
de Menezes JESA; Laboratório de Produtos Naturais, Centro de Ciência e Tecnologia, Universidade Estadual do Ceará, Campus Itaperi, 60714-903, Fortaleza, CE, Brasil. .
Ribeiro MENP; Laboratório de Polímeros e Inovação de Materiais, Departamento de Química Orgânica e Inorgânica, Centro de Ciências, Universidade Federal do Ceará, Campus do Pici, CE, 60455-760, Fortaleza, Brasil. .; Pokaż więcej
Źródło:: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences [Daru] 2023 Dec; Vol. 31 (2), pp. 183-192. Date of Electronic Publication: 2023 Aug 28.
Typ publikacji:: Journal Article
MeSH Terms:: Oils, Volatile*/pharmacology
Syzygium*/metabolism
Anti-Anxiety Agents*/pharmacology
Anti-Anxiety Agents*/metabolism
Animals ; Clove Oil/pharmacology ; Clove Oil/metabolism ; Zebrafish ; Eugenol/pharmacology ; Eugenol/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Pharmacological Manipulation of Corticotropin-Releasing Factor Receptors in the Anterior and Posterior Subregions of the Insular Cortex Differently Affects Anxiety-Like Behaviors in the Elevated Plus Maze in Rats.
Autorzy:: Lopes LM; Laboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil.
Reis-Silva LL; Laboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil.
Rodrigues B; Department of Adapted Physical Activity, Faculty of Physical Education, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.
Crestani CC; Laboratory of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2024 Jan 31; Vol. 2024, pp. 8322844. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Receptors, Corticotropin-Releasing Hormone*/metabolism
Anti-Anxiety Agents*/pharmacology
Aminopyridines*
Humans ; Rats ; Animals ; Corticotropin-Releasing Hormone/pharmacology ; Corticotropin-Releasing Hormone/metabolism ; Elevated Plus Maze Test ; Insular Cortex ; Anxiety/drug therapy ; Anxiety/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Anti-Anxiety Agents"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język